Mesoblast Limited

Total Valuation

Mesoblast Limited carries a market capitalization of 1.61B, placing it among publicly traded companies globally. Its enterprise value stands at 17.60B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Share Statistics

Mesoblast Limited currently has 1.30B shares outstanding.

Valuation Ratios

Financial Position

Mesoblast Limited maintains a current ratio of 2.43, meaning it holds 2.4x the short-term assets needed to cover near-term liabilities.

Stock Price Statistics

Mesoblast Limited's stock has declined approximately -29.68839% over the past 52 weeks. The 50-day moving average sits at 15.55, while the 200-day moving average is 15.66.

Balance Sheet

Mesoblast Limited holds 47.39M in cash and equivalents against 127.33M in total debt, resulting in a net debt position of 71.85M. Total book value stands at 568.41M, with working capital of 116.38M providing operational flexibility.

Cash Flow

Dividends & Yields

Stock Splits

Mesoblast Limited's most recent stock split took place on January 10, 2024 with a 2:1 split ratio.

Scores

Mesoblast Limited posts an Altman Z-Score of 44.81, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.